Univec, Inc. (UNVC)
- Previous Close
0.0049 - Open
0.0052 - Bid --
- Ask --
- Day's Range
0.0049 - 0.0052 - 52 Week Range
0.0025 - 0.0150 - Volume
171,635 - Avg. Volume
1,340,103 - Market Cap (intraday)
12.868M - Beta (5Y Monthly) -1.18
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0900 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. It primarily provides auto-disable and safety syringes. The company offers 1 cc AD-syringe for aspirating and non-aspirating applications, which are used for dispensing dosages of allergy, immunization, and insulin medicines. It also manufactures and markets sliding sheath syringes that are designed to protect patients and healthcare workers from needle stick injuries; and bifurcated needle safety syringes, which are used in administering smallpox vaccines in response to bio-terrorist threats. Univec markets its auto-disable syringes and sliding sheath safety syringes to private hospitals, health facilities, and distributors in the United States, as well as to governments of developing countries. In addition, it assists pharmaceutical companies in marketing, fulfillment, and tracking drug samples via an online system connecting pharmacies and managed payment providers. The company was founded in 1992 and is based in Baltimore, Maryland.
www.univec.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: UNVC
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UNVC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UNVC
Valuation Measures
Market Cap
12.87M
Enterprise Value
12.87M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
449.47
Enterprise Value/EBITDA
-40.65
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-43.76%
Return on Equity (ttm)
--
Revenue (ttm)
28.63k
Net Income Avi to Common (ttm)
-650.34k
Diluted EPS (ttm)
-0.0900
Balance Sheet and Cash Flow
Total Cash (mrq)
15.48k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
105.46k
Company Insights: UNVC
UNVC does not have Company Insights